Basic Information
SEROQUEL TABLET 300mg
TABLET, FILM COATED
Regulatory Information
SIN13236P
February 26, 2007
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XN05AH04
Company Information
LUYE PHARMA (SINGAPORE) PTE. LTD.
LUYE PHARMA (SINGAPORE) PTE. LTD.
Active Ingredients
QUETIAPINE FUMARATE 345 mg EQV QUETIAPINE (Core)
Strength: 300 mg
Detailed Information
Contraindications
**Contraindications** SEROQUEL is contraindicated in patients who are hypersensitive to any component of this product.
Indication Information
**Indications** SEROQUEL is indicated for the treatment of: - schizophrenia. - acute manic episodes associated with bipolar I disorder. - depressive episodes associated with bipolar disorder. - preventing recurrence in maintenance treatment of bipolar I disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate.